PMID- 23571126 OWN - NLM STAT- MEDLINE DCOM- 20131112 LR - 20220409 IS - 1873-264X (Electronic) IS - 0731-7085 (Linking) VI - 80 DP - 2013 Jun TI - Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box-Behnken statistical design. PG - 141-6 LID - S0731-7085(13)00106-4 [pii] LID - 10.1016/j.jpba.2013.02.038 [doi] AB - Chitosan nanoparticles and magnetic chitosan nanoparticles can be applied as delivery systems for the anti-Alzheimer drug tacrine. Investigation was carried out to elucidate the influence of process parameters on the mean particle size of chitosan nanoparticles produced by spontaneous emulsification. The method was optimized using design of experiments (DOE) by employing a 3-factor, 3-level Box-Behnken statistical design. This statistical design is used in order to achieve the minimum size and suitable morphology of nanoparticles. Also, magnetic chitosan nanoparticles were synthesized according to optimal method. The designed nanoparticles have average particle size from 33.64 to 74.87nm, which were determined by field emission scanning electron microscopy (FE-SEM). Drug loading in the nanoparticles as drug delivery systems has been done according to the presented optimal method and appropriate capacity of drug loading was shown by ultraviolet spectrophotometry. Chitosan and magnetic chitosan nanoparticles as drug delivery systems were characterized by Diffuse Reflectance Fourier Transform Mid Infrared spectroscopy (DR-FTMIR). CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Elmizadeh, Hamideh AU - Elmizadeh H AD - Department of Chemistry, Faculty of Science, IKIU, Qazvin, Iran. k.elmizadeh@yahoo.com FAU - Khanmohammadi, Mohammadreza AU - Khanmohammadi M FAU - Ghasemi, Keyvan AU - Ghasemi K FAU - Hassanzadeh, Gholamreza AU - Hassanzadeh G FAU - Nassiri-Asl, Marjan AU - Nassiri-Asl M FAU - Garmarudi, Amir Bagheri AU - Garmarudi AB LA - eng PT - Journal Article DEP - 20130318 PL - England TA - J Pharm Biomed Anal JT - Journal of pharmaceutical and biomedical analysis JID - 8309336 RN - 0 (Emulsions) RN - 0 (Magnetite Nanoparticles) RN - 0 (Nootropic Agents) RN - 4VX7YNB537 (Tacrine) RN - 9012-76-4 (Chitosan) SB - IM MH - Chitosan/*chemistry MH - Drug Compounding MH - Drug Delivery Systems MH - Emulsions MH - *Magnetite Nanoparticles MH - Microscopy, Electron, Scanning MH - *Nanoparticles MH - Nootropic Agents/administration & dosage MH - Particle Size MH - Spectroscopy, Fourier Transform Infrared/methods MH - Tacrine/*administration & dosage EDAT- 2013/04/11 06:00 MHDA- 2013/11/13 06:00 CRDT- 2013/04/11 06:00 PHST- 2012/10/04 00:00 [received] PHST- 2013/02/21 00:00 [revised] PHST- 2013/02/26 00:00 [accepted] PHST- 2013/04/11 06:00 [entrez] PHST- 2013/04/11 06:00 [pubmed] PHST- 2013/11/13 06:00 [medline] AID - S0731-7085(13)00106-4 [pii] AID - 10.1016/j.jpba.2013.02.038 [doi] PST - ppublish SO - J Pharm Biomed Anal. 2013 Jun;80:141-6. doi: 10.1016/j.jpba.2013.02.038. Epub 2013 Mar 18.